Tandem Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.7M | Sell |
53,044
-660
| -1% | -$70.9K | 2.88% | 7 |
|
|
2025
Q1 | $5.42M | Sell |
53,704
-842
| -2% | -$84.9K | 3.03% | 7 |
|
|
2024
Q4 | $4.87M | Sell |
54,546
-605
| -1% | -$54K | 2.61% | 8 |
|
|
2024
Q3 | $4.62M | Sell |
55,151
-2,715
| -5% | -$228K | 2.43% | 8 |
|
|
2024
Q2 | $4.42M | Sell |
57,866
-485
| -0.8% | -$37.1K | 2.42% | 10 |
|
|
2024
Q1 | $4M | Sell |
58,351
-125
| -0.2% | -$8.56K | 2.27% | 11 |
|
|
2023
Q4 | $3.38M | Sell |
58,476
-1,400
| -2% | -$80.9K | 2.1% | 12 |
|
|
2023
Q3 | $3.16M | Sell |
59,876
-450
| -0.7% | -$23.8K | 2.17% | 10 |
|
|
2023
Q2 | $3.26M | Sell |
60,326
-600
| -1% | -$32.5K | 2.13% | 12 |
|
|
2023
Q1 | $3.05M | Sell |
60,926
-478
| -0.8% | -$23.9K | 2.15% | 12 |
|
|
2022
Q4 | $2.84M | Sell |
61,404
-760
| -1% | -$35.2K | 2.24% | 12 |
|
|
2022
Q3 | $2.52M | Sell |
62,164
-90
| -0.1% | -$3.65K | 2.13% | 12 |
|
|
2022
Q2 | $2.32M | Hold |
62,254
| – | – | 1.86% | 17 |
|
|
2022
Q1 | $2.73M | Sell |
62,254
-520
| -0.8% | -$22.8K | 1.89% | 17 |
|
|
2021
Q4 | $2.67M | Buy |
62,774
+1,125
| +2% | +$47.8K | 1.54% | 24 |
|
|
2021
Q3 | $2.68M | Buy |
61,649
+280
| +0.5% | +$12.1K | 1.68% | 20 |
|
|
2021
Q2 | $2.62M | Sell |
61,369
-270
| -0.4% | -$11.5K | 1.65% | 21 |
|
|
2021
Q1 | $2.38M | Sell |
61,639
-550
| -0.9% | -$21.3K | 1.65% | 25 |
|
|
2020
Q4 | $2.24M | Buy |
62,189
+650
| +1% | +$23.4K | 1.68% | 23 |
|
|
2020
Q3 | $2.35M | Sell |
61,539
-300
| -0.5% | -$11.5K | 2.08% | 17 |
|
|
2020
Q2 | $2.17M | Sell |
61,839
-6,260
| -9% | -$220K | 2.13% | 16 |
|
|
2020
Q1 | $2.22M | Buy |
68,099
+2,020
| +3% | +$65.9K | 2.5% | 11 |
|
|
2019
Q4 | $2.99M | Buy |
+66,079
| New | +$2.99M | 2.56% | 7 |
|